“Since the primary endpoint as listed at clinicaltrials does not show any breakout for ventilation status or type of treatment site saying that it met the primary endpoint seems to be inaccurate.”

(Sarcasm) Looks like RLFTF drew up the NP Special (never admit failure) but has a better PR team. It’ll be interesting to see how the regulatory process for their trial pans out.